Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer
×
pembrolizumab
×
Clear all
Filters
3
NCT05286437
2025-12-30
LaPemERLA
National Cancer Centre, Singapore
Phase 2
Recruiting
40 enrolled